PainNCT05727969
Dexmedetomidine Infusion and Surgical Pleth Index In Pediatrics
A study testing Dexmedetomidine, Lactated Ringer and Hypospadias in people with Pain and Hypospadias, run by Fayoum University Hospital at 1 site in Egypt.
Trial summary
This non-invasive dimensionless score index -SPI-reflects the Patients' sympathetic response to surgical stimulation. Its effectiveness in detecting the balance between nociceptor activation and analgesia was not only reported but also, was reported to be superior to the other parameters like blood pressure and heart… Read more about this study
- Who is it for?
- Ages 1 year to 7 yearsHealthy volunteers can take part
- Conditions the study is for
- Pain, Hypospadias
- What is being tested?
- Dexmedetomidine, Lactated Ringer and Hypospadias
- Type of treatment
- Medical device, Surgery or procedure
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 90 participants
- Where
- 1 siteEgypt
- Study dates
- 15 Jan 2023to 15 Dec 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 1 year to 7 years
- All sexes
- Healthy volunteers accepted
- Child
Who may be able to join
- Age 1-7years.
- ASA physical status I-II.
- Hypospadias surgery.
Who cannot join
- Children having a history of mental retardation.
- Developmental delay.
- Allergic to dexmedetomedine.
- Neuraxial anesthesia.
- Cardiovascular disease.
Trial locations and contacts
1 site in 1 country.
Egypt1 site
Fayoum University hospital
El Fayoum Qesm, Faiyum Governorate, 63514
About this study
Official title: Effect Of Dexmedetomidine Infusion On Surgical Pleth Index In Pediatrics Undergoing Hypospadias Repair; A Prospective Observational Study
This non-invasive dimensionless score index -SPI-reflects the Patients' sympathetic response to surgical stimulation. Its effectiveness in detecting the balance between nociceptor activation and analgesia was not only reported but also, was reported to be superior to the other parameters like blood pressure and heart rate. SPI value is correlated to pain and ranges from 0 to 100, higher values indicate strong surgical stimulus. Its value is obtained from photoplethysmographic amplitude (PPGA) and heart rate (HR) data from pulse oximetry measurement.
Prediction of the severity of postoperative pain using SPI in both adults and children has been reported by several studies. So, the authors hypothesize that dexmedetomidine infusion without giving a bolus dose may affect the SPI in pediatrics undergoing hypospadias repair.
Read the detailed description
After obtaining Fayoum University's ethical committee permission and as well as the informed consent from the parents, 90 patients aged 1 to 7 years old scheduled for hypospadias repair will be randomly assigned into 2 groups.
Preoperative Assessment:
All patients will be assessed clinically and investigated for exclusion of any of the above-mentioned contraindications.
Perioperative Management:
Patients will receive no premedication. After entering the Operating room, All patients will be monitored using surgical pleth index, arterial blood pressure, pulse oximetry, and electrocardiography. The SPI value will be measured using Datex-Ohmeda (GE Healthcare,Madison,WI 53707-7550 USA) monitoring system.
Inhalational induction of general anesthesia (GA) will be performed with a face mask using sevoflurane 8% and 50% oxygen in the air, and then an intravenous (IV) cannula will be inserted.
Fentanyl will be administered intravenously at 1 μg/kg, atracurium 0.5 mg/kg and an endotracheal tube will be used to secure the airway.
Anesthesia will be maintained with 1% isoflurane, 50% oxygen in the air, and atracurium infusion (0.10 mg/kg).
During the operation, bradycardia is defined as a 30% decrease from the baseline HR, and hypotension is defined as a 30% decrease from the baseline MAP. In these cases, 0.01 mg/kg of atropine and 0.1 mg/kg of ephedrine, respectively, will be given intravenously. Additionally, tachycardia is defined as a 30% increase from the baseline HR, and hypertension is defined as a 30% increase from the baseline MAP. If either of these occurred, 0.1 μg/kg of fentanyl was given intravenously, and then the incidence was calculated and analyzed.
At the end of the surgery, acetaminophen 15 mg/kg IV will be administered to all patients. After completion of the surgical procedure and emergence from anesthesia, the patient will be referred to PACU. Quality of analgesia will be assessed using a face, legs, activity, cry, consolability (FLACC scale) at PACU discharge and 2, 4, 6, 12, and 24 hours postoperatively. Diclofenac sodium 1 mg/kg rectally will be given as rescue analgesia for patients in all study groups in PACU if the FLACC scale > 4. Nurses will be informed about the pain evaluation, to give the patients oral paracetamol 30 mg/kg. The data collectors from nurses will record data. The depth of sedation will be assessed using Ramsy sedation score (RSS) at PACU discharge and 2 hours postoperative by the investigators.
The patient will be discharged from PACU using The Modified Aldrete Score system after an assessment of the patient's activity, respiration, blood pressure, consciousness, and color, A score ≥ 9 is required for discharge from the PACU.
Adverse events like bradycardia hypotension excessive sedation respiratory depression postoperative agitation nausea and vomiting will be recorded during the first 24 hours.
Statistical analysis
- Sample size calculation was done using IBM SPSS version 29 for Windows. A total of 45 children per group are needed to be able to detect an expected difference in the SPI based on previous research.This sample size was estimated using a power of 80% and alpha of 0.05.
- Descriptive statistics for the variables will be presented in the form of mean with standard deviation or median with interquartile range for numeric variables, while frequencies and percentages will be used for categorical variables. Comparison of the two groups will be done after testing for normality of the distribution using Shapiro-wilk test. The analysis will be done using the independent samples t test or using the non-parametric Mann Whitney test for numerical variables. Categorical variables will be compared using Chi Square test or Fisher's exact test. IBM SPSS version 28 for Windows software will be used for the analysis. A p-value of < 0.05 will be considered statistically significant.
- Conditions
- Pain, Hypospadias
- Being tested
- Dexmedetomidine, Lactated Ringer, Hypospadias, Surgical pleth index
- Keywords
- Dexmedetomidine, Hypospadias, Postoperative analgesia, Surgical pleth index
- Medical subject headings
- Pain, Hypospadias
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
DexmedetomidineDrug
Also called Precedex
Dexmedetomidine at a a rate of 0.5 μg/kg/hour will be infused with induction of anesthesia.
Lactated RingerDrug
Also called Solution
Lactated ringer solution at a a rate of 0.5 μg/kg/hour will be infused with induction of anesthesia.
HypospadiasProcedure or surgery
Also called pediatric manuvere
Children who will undergone hypospadias surgery
Surgical pleth indexDevice
Also called SPI
The SPI value will be measured using Datex-Ohmeda (GE Healthcare,Madison,WI 53707-7550 USA) monitoring system.
| Study group | Role | What they receive |
|---|---|---|
| Control group | Placebo comparator | The control group, lactated ringer solution will be infused. Receives: Drug: Lactated Ringer; Procedure: Hypospadias; Device: Surgical pleth index |
| Dexmedetomidine group | Experimental | In the dexmedetomidine group, dexmedetomidine will be infused. Receives: Drug: Dexmedetomidine; Procedure: Hypospadias; Device: Surgical pleth index |
What is being measured
The primary outcome is the main question the study is designed to answer.
Surgical pleth index number
from 0 to 100, higher values indicate strong surgical stimulus
Measured: 1 minute at end of the operation after skin closure.
Secondary outcomes (27)
Surgical pleth index number
from 0 to 100, higher values indicate strong surgical stimulus
Measured: 1 minute before induction of anesthesia.
Surgical pleth index number
from 0 to 100, higher values indicate strong surgical stimulus
Measured: 1 minute after insertion of endotracheal tube.
Surgical pleth index number
from 0 to 100, higher values indicate strong surgical stimulus
Measured: 1 minute after beginning of surgery with skin incision.
Surgical pleth index number
from 0 to 100, higher values indicate strong surgical stimulus
Measured: 5 minutes after recovery at post anesthesia care unit.
Mean arterial blood pressure
in mmHg
Measured: 5 minutes after recovery at post anesthesia care unit.
Mean arterial blood pressure
in mmHg
Measured: 1 minute before induction of anesthesia.
Mean arterial blood pressure
in mmHg
Measured: 1 minute after beginning of surgery with skin incision.
Heart rate
beat/minute
Measured: 1 minute after beginning of surgery with skin incision.
Heart rate
beat/minute
Measured: 1 minute before induction of anesthesia.
Heart rate
beat/minute
Measured: 5 minutes after recovery at post anesthesia care unit.
Heart rate
beat/minute
Measured: 1 minute at end of the operation after skin closure.
Mean arterial blood pressure
mmHg
Measured: 1 minute at end of the operation after skin closure.
Need of vasoactive drugs
Yes or no
Measured: 1minute after infusion until end of surgery
FLACC pain score
F:face - L:legs - A:activity - C:cry - C:consolability for description of pain degree in children
Measured: 5 minutes after recovery in postanesthesia care unit
FLACC pain score
F:face - L:legs - A:activity - C:cry - C:consolability for description of pain degree in children
Measured: 2 hours after recovery in postanesthesia care unit
Ramsay sedation score
0:5 with 0:deeply sedation to 5:no sedation
Measured: 5 minutes after recovery in postanesthesia care unit
Ramsay sedation score
0:5 with 0:deeply sedation to 5:no sedation
Measured: 2 hours after recovery in postanesthesia care unit
FLACC pain score
F:face - L:legs - A:activity - C:cry - C:consolability for description of pain degree in children
Measured: 4 hours after discharge from recovery
FLACC pain score
F:face - L:legs - A:activity - C:cry - C:consolability for description of pain degree in children
Measured: 6 hours after discharge from recovery
FLACC pain score
F:face - L:legs - A:activity - C:cry - C:consolability for description of pain degree in children
Measured: 12 hours after discharge from recovery
FLACC pain score
F:face - L:legs - A:activity - C:cry - C:consolability for description of pain degree in children
Measured: 24 hours after discharge from recovery
Surgical time
from when the surgeon of record starts the procedure until complete skin closure in minutes
Measured: 1 minute after skin
Anesthesia time
from the start of anesthesia to the end of an anesthesia service in minutes
Measured: 5 minutes after insertion of endotracheal tube
Total opioid consumption
in milligram
Measured: 24 hours after operation
Time of 1st analgesia dose
time when first analgesic drug is injected for pain (in hours)
Measured: 24 hours postoperatively
Total non-steroidal consumption
time when first usage of non-steroidal anti-inflammatory drug is injected for pain (in hours)
Measured: 24 hours postoperatively
Extubation time
time from the end of surgery to airway extubation (in minutes)
Measured: 2 minutes after removal of endotracheal tube
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Feb 2023
- Study start15 Jan 2023
- Primary completion15 Nov 2023
- Study completion15 Dec 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for PainStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- The randomization will be computer generated random number and the randomization sequence will be kept hidden in sealed opaque envelopes just opened after recruitment and admittance to the operating room.
- Masking
- Triple blind
- Who is masked
- Participant, Investigator, Outcomes assessor
- Enrolment
- 90 participants (actual)
Sponsor and investigators
- Lead sponsor
- Fayoum University Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mohamed Ahmed Hamed, Fayoum University Hospital
- Investigators
- Safaa G Megahed, MD, Study director, Fayoum UniversityOmar S Mahmoud, MD, Study director, Fayoum University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05727969
- Sponsor's protocol ID
- M637
- Status last verified
- Feb 2024
- First submitted
- 24 Jan 2023
- Last updated
- 22 Feb 2024
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Huiku M, Uutela K, van Gils M, Korhonen I, Kymalainen M, Merilainen P, Paloheimo M, Rantanen M, Takala P, Viertio-Oja H, Yli-Hankala A. Assessment of surgical stress during general anaesthesia. Br J Anaesth. 2007 Apr;98(4):447-55. doi: 10.1093/bja/aem004. Epub 2007 Feb 28.
PubMed 17329347Hamunen K, Kontinen V, Hakala E, Talke P, Paloheimo M, Kalso E. Effect of pain on autonomic nervous system indices derived from photoplethysmography in healthy volunteers. Br J Anaesth. 2012 May;108(5):838-44. doi: 10.1093/bja/aes001. Epub 2012 Feb 26.
PubMed 22369767Constant I, Sabourdin N. Monitoring depth of anesthesia: from consciousness to nociception. A window on subcortical brain activity. Paediatr Anaesth. 2015 Jan;25(1):73-82. doi: 10.1111/pan.12586. Epub 2014 Nov 20.
PubMed 25410376
Study at a glance
From the registry record, last updated by the sponsor on 22 Feb 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect Of Dexmedetomidine Infusion On Surgical Pleth Index In Pediatrics Undergoing Hypospadias Repair; A Prospective Observational Study
- ClinicalTrials.gov ID
- NCT05727969
- Acronym / sponsor ID
- M637
- Conditions
- Pain, Hypospadias
- Keywords
- Dexmedetomidine, Hypospadias, Postoperative analgesia, Surgical pleth index
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 90 participants (actual)
- Lead sponsor
- Fayoum University HospitalUniversity, hospital or other
- Study start
- 15 Jan 2023 (actual)
- Primary completion
- 15 Nov 2023 (actual)
- Study completion
- 15 Dec 2023 (actual)
- First posted
- 14 Feb 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This non-invasive dimensionless score index -SPI-reflects the Patients' sympathetic response to surgical stimulation. Its effectiveness in detecting the balance between nociceptor activation and analgesia was not only reported but also, was reported to be superior to the other parameters like blood pressure and heart rate. SPI value is correlated to pain and ranges from 0 to 100, higher values indicate strong surgical stimulus. Its value is obtained from photoplethysmographic amplitude (PPGA) and heart rate (HR) data from pulse oximetry measurement.
Prediction of the severity of postoperative pain using SPI in both adults and children has been reported by several studies. So, the authors hypothesize that dexmedetomidine infusion without giving a bolus dose may affect the SPI in pediatrics undergoing hypospadias repair.
Detailed description
After obtaining Fayoum University's ethical committee permission and as well as the informed consent from the parents, 90 patients aged 1 to 7 years old scheduled for hypospadias repair will be randomly assigned into 2 groups.
Preoperative Assessment:
All patients will be assessed clinically and investigated for exclusion of any of the above-mentioned contraindications.
Perioperative Management:
Patients will receive no premedication. After entering the Operating room, All patients will be monitored using surgical pleth index, arterial blood pressure, pulse oximetry, and electrocardiography. The SPI value will be measured using Datex-Ohmeda (GE Healthcare,Madison,WI 53707-7550 USA) monitoring system.
Inhalational induction of general anesthesia (GA) will be performed with a face mask using sevoflurane 8% and 50% oxygen in the air, and then an intravenous (IV) cannula will be inserted.
Fentanyl will be administered intravenously at 1 μg/kg, atracurium 0.5 mg/kg and an endotracheal tube will be used to secure the airway.
Anesthesia will be maintained with 1% isoflurane, 50% oxygen in the air, and atracurium infusion (0.10 mg/kg).
During the operation, bradycardia is defined as a 30% decrease from the baseline HR, and hypotension is defined as a 30% decrease from the baseline MAP. In these cases, 0.01 mg/kg of atropine and 0.1 mg/kg of ephedrine, respectively, will be given intravenously. Additionally, tachycardia is defined as a 30% increase from the baseline HR, and hypertension is defined as a 30% increase from the baseline MAP. If either of these occurred, 0.1 μg/kg of fentanyl was given intravenously, and then the incidence was calculated and analyzed.
At the end of the surgery, acetaminophen 15 mg/kg IV will be administered to all patients. After completion of the surgical procedure and emergence from anesthesia, the patient will be referred to PACU. Quality of analgesia will be assessed using a face, legs, activity, cry, consolability (FLACC scale) at PACU discharge and 2, 4, 6, 12, and 24 hours postoperatively. Diclofenac sodium 1 mg/kg rectally will be given as rescue analgesia for patients in all study groups in PACU if the FLACC scale > 4. Nurses will be informed about the pain evaluation, to give the patients oral paracetamol 30 mg/kg. The data collectors from nurses will record data. The depth of sedation will be assessed using Ramsy sedation score (RSS) at PACU discharge and 2 hours postoperative by the investigators.
The patient will be discharged from PACU using The Modified Aldrete Score system after an assessment of the patient's activity, respiration, blood pressure, consciousness, and color, A score ≥ 9 is required for discharge from the PACU.
Adverse events like bradycardia hypotension excessive sedation respiratory depression postoperative agitation nausea and vomiting will be recorded during the first 24 hours.
Statistical analysis
- Sample size calculation was done using IBM SPSS version 29 for Windows. A total of 45 children per group are needed to be able to detect an expected difference in the SPI based on previous research.This sample size was estimated using a power of 80% and alpha of 0.05.
- Descriptive statistics for the variables will be presented in the form of mean with standard deviation or median with interquartile range for numeric variables, while frequencies and percentages will be used for categorical variables. Comparison of the two groups will be done after testing for normality of the distribution using Shapiro-wilk test. The analysis will be done using the independent samples t test or using the non-parametric Mann Whitney test for numerical variables. Categorical variables will be compared using Chi Square test or Fisher's exact test. IBM SPSS version 28 for Windows software will be used for the analysis. A p-value of < 0.05 will be considered statistically significant.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind (participant, investigator, outcomes assessor)
- Number of arms
- 2
- Model description
- The randomization will be computer generated random number and the randomization sequence will be kept hidden in sealed opaque envelopes just opened after recruitment and admittance to the operating room.
| Arm | Type | Receives |
|---|---|---|
| Control group | Placebo comparator | Drug: Lactated Ringer, Procedure: Hypospadias, Device: Surgical pleth indexThe control group, lactated ringer solution will be infused. |
| Dexmedetomidine group | Experimental | Drug: Dexmedetomidine, Procedure: Hypospadias, Device: Surgical pleth indexIn the dexmedetomidine group, dexmedetomidine will be infused. |
Who may qualify
- Ages
- 1 year to 7 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child
Key inclusion criteria (3 listed)
- Age 1-7years.
- ASA physical status I-II.
- Hypospadias surgery.
Key exclusion criteria (5 listed)
- Children having a history of mental retardation.
- Developmental delay.
- Allergic to dexmedetomedine.
- Neuraxial anesthesia.
- Cardiovascular disease.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| DexmedetomidineAlso: PrecedexDexmedetomidine at a a rate of 0.5 μg/kg/hour will be infused with induction of anesthesia. | Drug | Dexmedetomidine group |
| Lactated RingerAlso: SolutionLactated ringer solution at a a rate of 0.5 μg/kg/hour will be infused with induction of anesthesia. | Drug | Control group |
| HypospadiasAlso: pediatric manuvereChildren who will undergone hypospadias surgery | Procedure or surgery | Control group, Dexmedetomidine group |
| Surgical pleth indexAlso: SPIThe SPI value will be measured using Datex-Ohmeda (GE Healthcare,Madison,WI 53707-7550 USA) monitoring system. | Device | Control group, Dexmedetomidine group |
Primary outcome
Surgical pleth index number
Time frame: 1 minute at end of the operation after skin closure.
from 0 to 100, higher values indicate strong surgical stimulus
27 secondary outcomes
Surgical pleth index number
Time frame: 1 minute before induction of anesthesia.
Surgical pleth index number
Time frame: 1 minute after insertion of endotracheal tube.
Surgical pleth index number
Time frame: 1 minute after beginning of surgery with skin incision.
Surgical pleth index number
Time frame: 5 minutes after recovery at post anesthesia care unit.
Mean arterial blood pressure
Time frame: 5 minutes after recovery at post anesthesia care unit.
Mean arterial blood pressure
Time frame: 1 minute before induction of anesthesia.
Mean arterial blood pressure
Time frame: 1 minute after beginning of surgery with skin incision.
Heart rate
Time frame: 1 minute after beginning of surgery with skin incision.
Heart rate
Time frame: 1 minute before induction of anesthesia.
Heart rate
Time frame: 5 minutes after recovery at post anesthesia care unit.
Heart rate
Time frame: 1 minute at end of the operation after skin closure.
Mean arterial blood pressure
Time frame: 1 minute at end of the operation after skin closure.
Need of vasoactive drugs
Time frame: 1minute after infusion until end of surgery
FLACC pain score
Time frame: 5 minutes after recovery in postanesthesia care unit
FLACC pain score
Time frame: 2 hours after recovery in postanesthesia care unit
Ramsay sedation score
Time frame: 5 minutes after recovery in postanesthesia care unit
Ramsay sedation score
Time frame: 2 hours after recovery in postanesthesia care unit
FLACC pain score
Time frame: 4 hours after discharge from recovery
FLACC pain score
Time frame: 6 hours after discharge from recovery
FLACC pain score
Time frame: 12 hours after discharge from recovery
FLACC pain score
Time frame: 24 hours after discharge from recovery
Surgical time
Time frame: 1 minute after skin
Anesthesia time
Time frame: 5 minutes after insertion of endotracheal tube
Total opioid consumption
Time frame: 24 hours after operation
Time of 1st analgesia dose
Time frame: 24 hours postoperatively
Total non-steroidal consumption
Time frame: 24 hours postoperatively
Extubation time
Time frame: 2 minutes after removal of endotracheal tube
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Feb 2024.
- Background: PubMed 17329347Huiku M, Uutela K, van Gils M, Korhonen I, Kymalainen M, Merilainen P, Paloheimo M, Rantanen M, Takala P, Viertio-Oja H, Yli-Hankala A. Assessment of surgical stress during general anaesthesia. Br J Anaesth. 2007 Apr;98(4):447-55. doi: 10.1093/bja/aem004. Epub 2007 Feb 28.
- Background: PubMed 22369767Hamunen K, Kontinen V, Hakala E, Talke P, Paloheimo M, Kalso E. Effect of pain on autonomic nervous system indices derived from photoplethysmography in healthy volunteers. Br J Anaesth. 2012 May;108(5):838-44. doi: 10.1093/bja/aes001. Epub 2012 Feb 26.
- Background: PubMed 25410376Constant I, Sabourdin N. Monitoring depth of anesthesia: from consciousness to nociception. A window on subcortical brain activity. Paediatr Anaesth. 2015 Jan;25(1):73-82. doi: 10.1111/pan.12586. Epub 2014 Nov 20.
- Individual participant dataSharing planned: No
Related trials for Pain
Not yet recruiting
Effect of Stress Ball Use During Femoral Arterial Sheath Removal After Coronary Angiography
Femoral Arterial Sheath Removal, Stress Ball
Recruiting
Empowered Relief® for Cancer Survivors With Chronic Pain
Chronic Pain Due to Cancer, Pain Catastrophizing
RecruitingPhase 4
ESP Blocks for Posterior Spinal Fusion
Postoperative Pain
RecruitingObservational study
Pain Phenotypes in Individuals With Multiple Sclerosis
Multiple Sclerosis, Chronic Pain
Not yet recruiting
Effects of Hip Hinge Exercises on Pain, Range of Motion and Functional Disability in Non-specific Low Back Pain.
Low Back Pain
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Safaa G Megahed, MD study director
Fayoum University
Omar S Mahmoud, MD study director
Fayoum University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Dexmedetomidine, Lactated Ringer and Hypospadias in people with Pain and Hypospadias, run by Fayoum University Hospital at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 22 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Surgical pleth index number (time frame: 1 minute at end of the operation after skin closure.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05727969, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Feb 2024; AzTrials last refreshed its copy on 7 Nov 2026.